Table 4.
Characteristic | OR* | 95% CI | p Value | |
---|---|---|---|---|
Age (years) | ||||
<55 | REF | |||
55–64 | 0.69 | 0.45 | 1.06 | 0.09 |
65–74 | 0.36 | 0.22 | 0.58 | <0.001 |
75–84 | 0.59 | 0.32 | 1.08 | 0.09 |
85+ | 1.61 | 0.57 | 4.52 | 0.36 |
Deprivation | ||||
1 least deprived | REF | |||
2 | 1.03 | 0.66 | 1.62 | 0.88 |
3 | 1.10 | 0.68 | 1.77 | 0.71 |
4 | 0.93 | 0.55 | 1.56 | 0.78 |
5 most deprived | 3.00 | 1.64 | 5.50 | <0.001 |
Physical activity† | 0.88 | 0.82 | 0.95 | <0.001 |
Number of other LTC (excl BP) | ||||
0 | REF | |||
1 | 1.84 | 1.25 | 2.70 | 0.002 |
2+ | 7.30 | 4.45 | 11.93 | <0.001 |
Treatment* | ||||
Radio+chemo+surgery+hormone | REF | |||
Radio+chemo+surgery | 0.67 | 0.38 | 1.20 | 0.18 |
Radio+surgery | 0.51 | 0.29 | 0.90 | 0.02 |
Radio+surgery+hormone | 0.56 | 0.33 | 0.96 | 0.04 |
Surgery only | 1.00 | 0.55 | 1.84 | 0.99 |
Other | 0.92 | 0.53 | 1.58 | 0.76 |
Ethnicity | ||||
White | REF | |||
Mixed | 0.50 | 0.06 | 4.29 | 0.53 |
Asian | 1.96 | 0.77 | 5.01 | 0.16 |
Black | 0.29 | 0.08 | 0.98 | 0.05 |
Other | 2.20 | 0.17 | 29.32 | 0.55 |
Disease status | ||||
Remission | REF | |||
Rx but present | 1.49 | 0.56 | 3.93 | 0.43 |
Not treated | . | . | . | . |
Recurrence | 4.70 | 1.92 | 11.52 | 0.001 |
Not sure | 2.51 | 1.27 | 4.96 | 0.008 |
Time since diagnosis (years) | ||||
1 | REF | |||
2 | 1.02 | 0.64 | 1.62 | 0.95 |
3 | 0.88 | 0.55 | 1.41 | 0.60 |
5 | 0.93 | 0.59 | 1.47 | 0.76 |
*Odds of reporting ‘medium’ or ‘low’ QoL EQ5D scores compared with ‘high’ QoL scores where ‘high’, ‘medium’ and ‘low’ QoL was defined as scores=1, 0.5≤scores<1 and scores<0.5, respectively.
†Amount of physical activity performed each week quantified according to the Chief Medical Officer of England's recommendations.16
LTC, long-term condition; QoL, quality of life.